Suppr超能文献

支气管扩张症肺部恶化的生物学。

The biology of pulmonary exacerbations in bronchiectasis.

机构信息

Dept of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

Respiratory Unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

出版信息

Eur Respir Rev. 2019 Nov 20;28(154). doi: 10.1183/16000617.0055-2019. Print 2019 Dec 31.

Abstract

Bronchiectasis is a heterogeneous chronic disease. Heterogeneity characterises bronchiectasis not only in the stable state but also during exacerbations, despite evidence on clinical and biological aspects of bronchiectasis, exacerbations still remain poorly understood.Although the scientific community recognises that bacterial infection is a cornerstone in the development of bronchiectasis, there is a lack of data regarding other trigger factors for exacerbations. In addition, a huge amount of data suggest a primary role of neutrophils in the stable state and exacerbation of bronchiectasis, but the inflammatory reaction involves many other additional pathways. Cole's vicious cycle hypothesis illustrates how airway dysfunction, airway inflammation, infection and structural damage are linked. The introduction of the concept of a "vicious vortex" stresses the complexity of the relationships between the components of the cycle. In this model of disease, exacerbations work as a catalyst, accelerating the progression of disease. The roles of microbiology and inflammation need to be considered as closely linked and will need to be investigated in different ways to collect samples. Clinical and translational research is of paramount importance to achieve a better comprehension of the pathophysiology of bronchiectasis, microbiology and inflammation both in the stable state and during exacerbations.

摘要

支气管扩张症是一种异质性的慢性疾病。尽管在支气管扩张症的临床和生物学方面已经有了一些证据,但支气管扩张症在稳定期和加重期仍然表现出明显的异质性。尽管科学界认识到细菌感染是支气管扩张症发展的基石,但对于加重期的其他触发因素的数据仍然缺乏。此外,大量数据表明中性粒细胞在支气管扩张症的稳定期和加重期发挥主要作用,但炎症反应还涉及许多其他途径。科尔的恶性循环假说说明了气道功能障碍、气道炎症、感染和结构损伤之间的联系。“恶性循环”这一概念的引入强调了循环各组成部分之间关系的复杂性。在这种疾病模型中,加重期作为一种催化剂,加速了疾病的进展。微生物学和炎症的作用需要被视为密切相关,并需要通过不同的方法来收集样本进行研究。临床和转化研究对于更好地理解支气管扩张症的病理生理学、微生物学和炎症在稳定期和加重期的作用至关重要。

相似文献

1
The biology of pulmonary exacerbations in bronchiectasis.
Eur Respir Rev. 2019 Nov 20;28(154). doi: 10.1183/16000617.0055-2019. Print 2019 Dec 31.
2
Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis.
Am J Respir Crit Care Med. 2012 Oct 1;186(7):657-65. doi: 10.1164/rccm.201203-0487OC. Epub 2012 Jun 28.
4
Advances in pharmacotherapy for bronchiectasis in adults.
Expert Opin Pharmacother. 2023 Jun;24(9):1075-1089. doi: 10.1080/14656566.2023.2210763. Epub 2023 May 9.
5
Bronchiectasis exacerbation: a narrative review of causes, risk factors, management and prevention.
Ann Transl Med. 2023 Jan 15;11(1):25. doi: 10.21037/atm-22-3437. Epub 2022 Nov 16.
6
Positive expiratory pressure therapy versus other airway clearance techniques for bronchiectasis.
Cochrane Database Syst Rev. 2017 Sep 27;9(9):CD011699. doi: 10.1002/14651858.CD011699.pub2.
7
Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.
Int J Chron Obstruct Pulmon Dis. 2018 Mar 2;13:761-769. doi: 10.2147/COPD.S139776. eCollection 2018.
8
The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study.
Lancet Respir Med. 2021 Aug;9(8):885-896. doi: 10.1016/S2213-2600(20)30557-9. Epub 2021 May 4.
9
Airway clearance techniques for bronchiectasis.
Cochrane Database Syst Rev. 2013 May 31(5):CD008351. doi: 10.1002/14651858.CD008351.pub2.

引用本文的文献

1
Clinical significance of respiratory bacteria and mycobacteria isolates in adult bronchiectasis in Taiwan.
ERJ Open Res. 2025 Jul 14;11(4). doi: 10.1183/23120541.00865-2024. eCollection 2025 Jul.
3
Utilization of Inhaled Antibiotics in Pediatric Non-Cystic Fibrosis Bronchiectasis: A Comprehensive Review.
Antibiotics (Basel). 2025 Feb 7;14(2):165. doi: 10.3390/antibiotics14020165.
4
Clinical characteristics and outcome of non-cystic fibrosis bronchiectasis in children: A tertiary care perspective.
SAGE Open Med. 2025 Feb 19;13:20503121251320849. doi: 10.1177/20503121251320849. eCollection 2025.
5
Bronchiectasis-COPD Overlap Syndrome: A Comprehensive Review of its Pathophysiology and Potential Cardiovascular Implications.
Ther Adv Pulm Crit Care Med. 2024 Dec 9;19:29768675241300808. doi: 10.1177/29768675241300808. eCollection 2024 Jan-Dec.
6
Applicability and Validity of the "Bronchiectasis Severity Index" (BSI) and "FACED" Score in Adult Aboriginal Australians.
Int J Chron Obstruct Pulmon Dis. 2024 Dec 4;19:2611-2628. doi: 10.2147/COPD.S482848. eCollection 2024.
7
Necrotizing pneumonia-a rare but complex complication in bronchiectasis patients.
Respirol Case Rep. 2024 Dec 3;12(12):e70080. doi: 10.1002/rcr2.70080. eCollection 2024 Dec.
9
Modulator-refractory cystic fibrosis: Defining the scope and challenges of an emerging at-risk population.
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241297877. doi: 10.1177/17534666241297877.
10
Characteristics of exacerbators in the US Bronchiectasis and NTM Research Registry: a cross-sectional study.
ERJ Open Res. 2024 Nov 11;10(6). doi: 10.1183/23120541.00185-2024. eCollection 2024 Nov.

本文引用的文献

1
Comparison of different conditions for DNA extraction in sputum - a pilot study.
Multidiscip Respir Med. 2019 Jan 31;14:6. doi: 10.1186/s40248-018-0166-z. eCollection 2019.
2
British Thoracic Society Guideline for bronchiectasis in adults.
Thorax. 2019 Jan;74(Suppl 1):1-69. doi: 10.1136/thoraxjnl-2018-212463.
4
New Insights Into the Epidemiology of Bronchiectasis.
Chest. 2018 Dec;154(6):1272-1273. doi: 10.1016/j.chest.2018.08.1051.
5
A comprehensive approach to lung function in bronchiectasis.
Respir Med. 2018 Dec;145:120-129. doi: 10.1016/j.rmed.2018.10.031. Epub 2018 Nov 2.
7
How to Process Sputum Samples and Extract Bacterial DNA for Microbiota Analysis.
Int J Mol Sci. 2018 Oct 20;19(10):3256. doi: 10.3390/ijms19103256.
8
Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity.
Lancet. 2018 Sep 8;392(10150):880-890. doi: 10.1016/S0140-6736(18)31767-7.
9
Treatable traits in bronchiectasis.
Eur Respir J. 2018 Sep 6;52(3). doi: 10.1183/13993003.01269-2018. Print 2018 Sep.
10
Introduction to Techniques and Methodologies for Characterizing the Human Respiratory Virome.
Methods Mol Biol. 2018;1838:111-123. doi: 10.1007/978-1-4939-8682-8_9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验